WA People
BILL · 2013–14 SESSION

HB 1528: Biological product prescrips

Concerning the prescription of biological products and interchangeable biosimilar products.

Summary

  • Authorizes biosimilar products to be substituted in the place of a biological product if the United States Food and Drug Administration has determined that the biosimilar product is interchangeable with the biological product.

From the House Bill Analysis 2013 (HB 1528), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 29, 2013
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Eileen Cody (D-34)
Introduced
January 29, 2013 in the House
Last action
January 13, 2014
Companion bill
SB 5469

AN ACT Relating to the prescription of biological products and interchangeable biosimilar products;

Sponsors

Prime sponsor: Eileen Cody (D-34)

3 co-sponsors (2 Democrats, 1 Republican)

Paul Harris R-17Dawn Morrell D-25Cindy Ryu D-32

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. First reading, referred to Health Care & Wellness.

HB 1528 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page